<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04352894</url>
  </required_header>
  <id_info>
    <org_study_id>AOBrescia_baiocchi_ICG1</org_study_id>
    <nct_id>NCT04352894</nct_id>
  </id_info>
  <brief_title>Intraoperative ICG Fluorescence Imaging for Peritoneal Carcinomatosis Detection</brief_title>
  <official_title>Indocyanine Green Fluorescence Detection of Peritoneal Carcinomatosis During Staging Laparoscopy for Gastric Cancer: Protocol for a Prospective Multicentric Single Arm Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background. Peritoneal carcinomatosis is a frequent and deadly localization of gastric&#xD;
      cancer. Available imaging techniques have a low accuracy in detecting small peritoneal&#xD;
      nodules, and direct laparoscopic visualization may fail too. A more accurate staging&#xD;
      technique would be advantageous for individualization of therapeutic path. Indocyanine Green&#xD;
      (ICG) fluorescence imaging has been reported as a tool for visualizing small peritoneal&#xD;
      seedings due to the &quot;enhanced permeability and retention&quot; (EPR) effect of cancer nodules.&#xD;
&#xD;
      Aim. To explore the feasibility and effectiveness of fluorescence-enhanced peritoneal&#xD;
      carcinomatosis detection in patients with gastric cancer undergoing staging laparoscopy.&#xD;
&#xD;
      Methods. This prospective, multicentric, single arm study will include patients with gastric&#xD;
      cancer, without a radiological suspicion of peritoneal carcinomatosis, undergoing staging&#xD;
      laparoscopy. An intravenous injection of ICG is given at different dosage and at different&#xD;
      timepoints before the intervention. During the staging laparoscopy, the abdominal cavity&#xD;
      exploration is performed using standard white-light, and subsequently using fluorescence&#xD;
      imaging. Suspicious nodules are harvested, until a maximum of 5 per patient, and sent for&#xD;
      definitive histological examination. Peritoneal washing is also harvested for cytologic&#xD;
      assessment in all cases. The eventual benefit of fluorescence imaging in terms of additional&#xD;
      peritoneal lesions that were not detected during standard white-light imaging is evaluated.&#xD;
&#xD;
      Discussion. This study will establish if fluorescence imaging increases sensitivity and/or&#xD;
      specificity of staging laparoscopy in detecting peritoneal carcinomatosis from gastric&#xD;
      cancer. Improved accuracy may translate in better care path selection.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2020</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Best modality of ICG injection</measure>
    <time_frame>intra-operative assessment</time_frame>
    <description>best timing of injection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity of ICG fluorescence</measure>
    <time_frame>intra-operative assessment</time_frame>
    <description>As compared with white light</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Peritoneal Carcinomatosis</condition>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>fluorescence guided peritoneal exploration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Indocyanine green (ICG) intravenous injection and peritoneal exploration with technology able to detect fluorescence generated by ICG</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Fluorescence guided peritoneal exploration</intervention_name>
    <description>Intravenous injection of ICG</description>
    <arm_group_label>fluorescence guided peritoneal exploration</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age of â‰¥18years&#xD;
&#xD;
          2. Ability to provide written informed consent&#xD;
&#xD;
          3. Histologically confirmed gastric adenocarcinoma or oesophago-gastric junction&#xD;
             adenocarcinoma Siewert 2 and 3&#xD;
&#xD;
          4. cT&gt;1&#xD;
&#xD;
          5. cM0 (clinical staging: no metastases)&#xD;
&#xD;
          6. Staging laparoscopy is indicated by the internal work-up protocol&#xD;
&#xD;
          7. Staging laparoscopy is in accordance with NCCN (National Comprehensive Cancer Network)&#xD;
             guidelines&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pregnancy&#xD;
&#xD;
          2. Iodine allergy/sensibility&#xD;
&#xD;
          3. Clinical P1 (defined as high probability of peritoneal carcinomatosis at imaging)&#xD;
&#xD;
          4. Investigator judgement that the patient should not participate for any reason&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gian Luca Baiocchi, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>ASST Spedali Civili, University of Brescia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gian Luca Baiocchi, Prof.</last_name>
    <phone>++39 338 5949921</phone>
    <email>gianluca.baiocchi@unibs.it</email>
  </overall_contact>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 14, 2020</study_first_submitted>
  <study_first_submitted_qc>April 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2020</study_first_posted>
  <last_update_submitted>April 17, 2020</last_update_submitted>
  <last_update_submitted_qc>April 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia</investigator_affiliation>
    <investigator_full_name>Gian Luca Baiocchi</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Peritoneal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

